马萨诸塞州在 COVID-19 的德尔塔和奥密克戎波期间的超额死亡率。
Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
机构信息
Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut.
出版信息
JAMA. 2022 Jul 5;328(1):74-76. doi: 10.1001/jama.2022.8045.
Abstract
This modeling study estimates the excess deaths attributable to COVID-19 disease in Massachusetts during the Delta (June to December 2021) and Omicron (December 2021 to February 2022) waves.
摘要
本建模研究估计了 2021 年 6 月至 12 月德尔塔（Delta）和 2021 年 12 月至 2022 年 2 月奥密克戎（Omicron）期间马萨诸塞州归因于 COVID-19 疾病的超额死亡人数。
相似文献
1
Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.马萨诸塞州在 COVID-19 的德尔塔和奥密克戎波期间的超额死亡率。
JAMA. 2022 Jul 5;328(1):74-76. doi: 10.1001/jama.2022.8045.
2
Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.马萨诸塞州关于新冠病毒德尔塔和奥密克戎毒株流行期间超额死亡率的数据。
JAMA. 2022 Nov 15;328(19):1977. doi: 10.1001/jama.2022.16729.
3
Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.墨西哥接种疫苗后，德尔塔和奥密克戎 SARS-CoV-2 波期间成年人 COVID-19 不良结局减少。
Front Public Health. 2022 Sep 13;10:1010256. doi: 10.3389/fpubh.2022.1010256. eCollection 2022.
4
Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.英国 ZOE COVID 研究应用程序 348691 名用户中德尔塔和奥密克戎变异株流行期间的 SARS-CoV-2 感染的皮肤表现。
Br J Dermatol. 2022 Dec;187(6):900-908. doi: 10.1111/bjd.21784. Epub 2022 Oct 10.
5
Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.马萨诸塞州关于新冠疫情德尔塔和奥密克戎毒株浪潮期间超额死亡率的数据。
JAMA. 2022 Nov 15;328(19):1977-1978. doi: 10.1001/jama.2022.16726.
6
Place of Death and End-of-Life Care Utilization among COVID-19 Decedents in a Massachusetts Health Care System.马萨诸塞州医疗系统中新冠病毒病死者的死亡地点及临终关怀利用情况
J Palliat Med. 2021 Mar;24(3):322-323. doi: 10.1089/jpm.2020.0674. Epub 2020 Nov 17.
7
SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel.在以色列，自身免疫性风湿病患者中的 SARS-CoV-2 感染；Delta 波和奥密克戎波之间的比较。
Semin Arthritis Rheum. 2023 Feb;58:152129. doi: 10.1016/j.semarthrit.2022.152129. Epub 2022 Nov 21.
8
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
9
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
10
Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study.德尔塔和奥密克戎变异株流行期间因 SARS-CoV-2 住院的儿科患者：澳大利亚单中心回顾性研究。
BMJ Paediatr Open. 2023 Mar;7(1). doi: 10.1136/bmjpo-2023-001874.
引用本文的文献
1
Declining Myocarditis Mortality in the United States and the Impact of the COVID-19 Pandemic.美国心肌炎死亡率的下降以及新冠疫情的影响
J Clin Med. 2025 Jul 18;14(14):5116. doi: 10.3390/jcm14145116.
2
Advancing pathogen detection for airborne diseases.推进空气传播疾病的病原体检测。
Fundam Res. 2022 Oct 31;3(4):520-524. doi: 10.1016/j.fmre.2022.10.011. eCollection 2023 Jul.
3
Identification of aberrant interferon-stimulated gene associated host responses potentially linked to poor prognosis in COVID-19 during the Omicron wave.在奥密克戎毒株流行期间，鉴定与新冠病毒感染预后不良潜在相关的异常干扰素刺激基因相关宿主反应。
Virol J. 2025 Mar 28;22(1):89. doi: 10.1186/s12985-025-02696-9.
4
Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic.新冠大流行期间特定年龄段全因死亡率的种族和民族差异。
JAMA Netw Open. 2024 Oct 1;7(10):e2438918. doi: 10.1001/jamanetworkopen.2024.38918.
5
Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study.感染SARS-CoV-2的肝硬化患者病死率的降低：一项全国性COVID队列合作研究。
Clin Gastroenterol Hepatol. 2025 Mar;23(4):591-601.e2. doi: 10.1016/j.cgh.2024.07.028. Epub 2024 Aug 23.
6
Assessing Excess Mortality of Baby Boomers from the COVID-19 Pandemic: Taiwan Omicron-naïve Cohort.评估新冠疫情对婴儿潮一代超额死亡率的影响：台湾奥密克戎零经验队列。
J Epidemiol Glob Health. 2024 Sep;14(3):1113-1121. doi: 10.1007/s44197-024-00262-0. Epub 2024 Jun 20.
7
The Main Mechanisms of Mesenchymal Stem Cell-Based Treatments against COVID-19.基于间充质干细胞的 COVID-19 治疗的主要机制。
Tissue Eng Regen Med. 2024 Jun;21(4):545-556. doi: 10.1007/s13770-024-00633-5. Epub 2024 Apr 4.
8
The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period.新冠病毒感染及新冠长期症状的病程：确定在奥密克戎毒株占主导期间之前和期间感染该疾病患者的风险因素。
Pathogens. 2024 Mar 20;13(3):267. doi: 10.3390/pathogens13030267.
9
Multilayer factors associated with excess all-cause mortality during the omicron and non-omicron waves of the COVID-19 pandemic: time series analysis in 29 countries.与 COVID-19 大流行的奥密克戎和非奥密克戎波期间全因超额死亡率相关的多层因素：29 个国家的时间序列分析。
BMC Public Health. 2024 Feb 2;24(1):350. doi: 10.1186/s12889-024-17803-8.
10
Comparing methods to predict baseline mortality for excess mortality calculations.比较预测超额死亡率计算基线死亡率的方法。
BMC Med Res Methodol. 2023 Oct 18;23(1):239. doi: 10.1186/s12874-023-02061-w.
本文引用的文献
1
Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.推断新冠病毒奥密克戎变种内在严重性的挑战。
N Engl J Med. 2022 Feb 17;386(7):e14. doi: 10.1056/NEJMp2119682. Epub 2022 Feb 2.
2
Disparities in Excess Mortality Associated with COVID-19 - United States, 2020.与 COVID-19 相关的超额死亡率差异-美国，2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Aug 20;70(33):1114-1119. doi: 10.15585/mmwr.mm7033a2.
3
Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021.2020年3月1日至2021年1月2日美国因新冠病毒病及其他原因导致的超额死亡人数
JAMA. 2021 Apr 2;325(17):1786-9. doi: 10.1001/jama.2021.5199.
4
All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020.2020 年 3 月至 7 月，美国 25-44 岁成年人全因超额死亡率和与 COVID-19 相关的死亡率。
JAMA. 2021 Feb 23;325(8):785-787. doi: 10.1001/jama.2020.24243.
5
COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries.COVID-19 与美国和 18 个对比国家的全因超额死亡率
JAMA. 2020 Nov 24;324(20):2100-2102. doi: 10.1001/jama.2020.20717.
Zotero 插件